Evidence map›Paper›PMID 34607068›Full record

ReviewClinics and research in hepatology and gastroenterology2022

Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children.

Francesco Pegoraro, Sandra Trapani, Giuseppe Indolfi

Open access · greenAbstract readReview
In one paragraph

Review in Clinics and research in hepatology and gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Susceptibility of SARS-CoV2 infection in children.European journal of pediatrics · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Francesco PegoraroDepartment of Health Science, Meyer Children's Hospital, Firenze, Italy.
Sandra TrapaniDepartment of Health Science, Meyer Children's Hospital, Firenze, Italy.
Giuseppe IndolfiNEUROFARBA Department, Meyer Children's Hospital, Firenze, Italy. Electronic address: giuseppe.indolfi@unifi.it.
Meyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a well-established respiratory tract pathogen. Recent studies in adults and children have shown an increasing number of patients reporting gastrointestinal manifestations of SARS-CoV-2 infection such as diarrhoea, nausea, vomiting and abdominal pain. SARS-CoV-2 RNA can be detected in faeces for an extended period, even after respiratory samples have tested negative and patients are asymptomatic. However, faecal-oral transmission has not yet been proven. In this article, the latest evidence on gastrointestinal, hepato-biliary, and pancreatic manifestations in children with coronavirus disease-19 and multisystem inflammatory syndrome will be analysed.

Indexed as

COVID-19Gastrointestinal DiseasesAdultChildGastrointestinal TractHumansRNA, ViralSARS-CoV-2Systemic Inflammatory Response SyndromeRNA, ViralChildrenCoronavirus-19GastrointestinalLiverPancreas

Identifiers

PMID34607068
PMCPMC8486685
OpenAlexW3204198267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.